Idiopathic dilated cardiomyopathy

Catherine E. Cooke; Michael D. Greenberg; Steven S. Coughlin; Kenneth Mishark; Masato Odawara; Kamejiro Yamashita; Sewa S. Legha; G. W. Dec; Valentin Fuster

doi:10.1056/NEJM199505183322015

Idiopathic dilated cardiomyopathy

Catherine E. Cooke, Michael D. Greenberg, Steven S. Coughlin, Kenneth Mishark, Masato Odawara, Kamejiro Yamashita, Sewa S. Legha, G. W. Dec, Valentin Fuster

Research output: Contribution to journal › Letter › peer-review

6 Scopus citations

Abstract

To the Editor: Dec and Fuster (Dec. 8 issue)¹ categorized the use of beta-blockers in patients with idiopathic dilated cardiomyopathy as investigational. There is now sufficient evidence to support their use as adjunctive therapy. Numerous clinical trials have evaluated the use of beta-blockers in conjunction with angiotensin-converting—enzyme inhibitors, nitrates, diuretics, and digoxin in patients with idiopathic dilated cardiomyopathy and have found improvements in ejection fraction, cardiac index, and New York Heart Association class and a decreased number of hospital admissions and cardiac transplantations.²—⁴ However, there have been trials⁵,⁶ that did not show such improvements. This is probably because.

Original language	English (US)
Pages (from-to)	1384-1386
Number of pages	3
Journal	New England Journal of Medicine
Volume	332
Issue number	20
DOIs	https://doi.org/10.1056/NEJM199505183322015
State	Published - May 18 1995
Externally published	Yes

ASJC Scopus subject areas

General Medicine

Access to Document

10.1056/NEJM199505183322015

Cite this

@article{30c7482b8258448391175ba8a054bfae,

title = "Idiopathic dilated cardiomyopathy",

abstract = "To the Editor: Dec and Fuster (Dec. 8 issue)1 categorized the use of beta-blockers in patients with idiopathic dilated cardiomyopathy as investigational. There is now sufficient evidence to support their use as adjunctive therapy. Numerous clinical trials have evaluated the use of beta-blockers in conjunction with angiotensin-converting—enzyme inhibitors, nitrates, diuretics, and digoxin in patients with idiopathic dilated cardiomyopathy and have found improvements in ejection fraction, cardiac index, and New York Heart Association class and a decreased number of hospital admissions and cardiac transplantations.2—4 However, there have been trials5,6 that did not show such improvements. This is probably because.",

author = "Cooke, {Catherine E.} and Greenberg, {Michael D.} and Coughlin, {Steven S.} and Kenneth Mishark and Masato Odawara and Kamejiro Yamashita and Legha, {Sewa S.} and Dec, {G. W.} and Valentin Fuster",

year = "1995",

month = may,

day = "18",

doi = "10.1056/NEJM199505183322015",

language = "English (US)",

volume = "332",

pages = "1384--1386",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "20",

}

TY - JOUR

T1 - Idiopathic dilated cardiomyopathy

AU - Cooke, Catherine E.

AU - Greenberg, Michael D.

AU - Coughlin, Steven S.

AU - Mishark, Kenneth

AU - Odawara, Masato

AU - Yamashita, Kamejiro

AU - Legha, Sewa S.

AU - Dec, G. W.

AU - Fuster, Valentin

PY - 1995/5/18

Y1 - 1995/5/18

N2 - To the Editor: Dec and Fuster (Dec. 8 issue)1 categorized the use of beta-blockers in patients with idiopathic dilated cardiomyopathy as investigational. There is now sufficient evidence to support their use as adjunctive therapy. Numerous clinical trials have evaluated the use of beta-blockers in conjunction with angiotensin-converting—enzyme inhibitors, nitrates, diuretics, and digoxin in patients with idiopathic dilated cardiomyopathy and have found improvements in ejection fraction, cardiac index, and New York Heart Association class and a decreased number of hospital admissions and cardiac transplantations.2—4 However, there have been trials5,6 that did not show such improvements. This is probably because.

AB - To the Editor: Dec and Fuster (Dec. 8 issue)1 categorized the use of beta-blockers in patients with idiopathic dilated cardiomyopathy as investigational. There is now sufficient evidence to support their use as adjunctive therapy. Numerous clinical trials have evaluated the use of beta-blockers in conjunction with angiotensin-converting—enzyme inhibitors, nitrates, diuretics, and digoxin in patients with idiopathic dilated cardiomyopathy and have found improvements in ejection fraction, cardiac index, and New York Heart Association class and a decreased number of hospital admissions and cardiac transplantations.2—4 However, there have been trials5,6 that did not show such improvements. This is probably because.

UR - http://www.scopus.com/inward/record.url?scp=0029647395&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029647395&partnerID=8YFLogxK

U2 - 10.1056/NEJM199505183322015

DO - 10.1056/NEJM199505183322015

M3 - Letter

C2 - 7772174

AN - SCOPUS:0029647395

SN - 0028-4793

VL - 332

SP - 1384

EP - 1386

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 20

ER -

Idiopathic dilated cardiomyopathy

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this